• Home
  • Mutual Funds
  • Nippon India Nifty Pharma ETF Growth

Nippon India Nifty Pharma ETF Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Nippon India Nifty Pharma ETF Growth Fund Overview

Min. investment

SIP ₹0 & Lump. ₹1000

AUM (Fund size)

₹1,570 Cr

Lock In Period

N/A

Expense Ratio

N/A

Exit Load

Nil

Benchmark

Nifty Pharma Total Return

Summary

Nippon India Nifty Pharma ETF Growth NAV is ₹25.1097 as of 23 Jun, 2026. Nippon India Nifty Pharma ETF Growth has delivered 86.12% returns since its launch. The minimum SIP investment amount in Nippon India Nifty Pharma ETF Growth is ₹0. The AUM of Nippon India Nifty Pharma ETF Growth is ₹1,570 Cr. The expense ratio of the fund is N/A%, and its benchmark is Nifty Pharma Total Return. The current exit load of the fund is Nil. In the last 1M months, Nippon India Nifty Pharma ETF Growth has delivered -1.86% returns.

Nippon India Nifty Pharma ETF Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M-1.86-0.6311.43
6M7.881.1538.47
1Y13.153.64117.55
3Y23.0112.21222.99

Portfolio Analysis

  • Equity: 99.95%
  • Debt: 0.05%
  • Others
As on: 2026-05-31
View allocation % by

1. Sun Pharmaceutical Industries Limited21.42%
2. Divi's Laboratories Limited9.53%
3. Dr. Reddy's Laboratories Limited8.93%
4. Cipla Limited8.86%
5. Lupin Limited6.18%
6. Laurus Labs Limited5.96%
7. Torrent Pharmaceuticals Limited5.19%
8. Aurobindo Pharma Limited4.48%
9. Glenmark Pharmaceuticals Limited3.85%
10. Alkem Laboratories Limited3.62%
11. Biocon Limited3.44%
12. Zydus Lifesciences Limited3.03%
13. Mankind Pharma Limited3.02%
14. IPCA Laboratories Limited2.38%
15. Gland Pharma Limited2.01%
16. JB Chemicals & Pharmaceuticals Limited2.00%
17. Wockhardt Limited1.89%
18. Abbott India Limited1.57%
19. Ajanta Pharma Limited1.39%
20. Piramal Pharma Limited1.20%

About Fund Nippon India Nifty Pharma ETF Growth

Nippon India Nifty Pharma ETF Growth managed by Nippon India Mutual Fund,is a Equity - Index Fundscheme with Assets Under Management of ₹1,570 Crore. The fund benchmarks its performance against the Nifty Pharma Total Return while maintaining an expense ratio of . Under the expert guidance of Jitendra Tolani ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Jitendra Tolani

Mr. Jitendra Tolani holds MBA (FINANCE). Prior to joining Nippon Mutual Fund, he was working with Motilal Oswal Financial Services Ltd, Asit C Mehta Investment Interrmediaries Ltd.

Peer Comparison

Fund NameRatingsAUMExpense Ratio
ICICI Prudential Nifty Auto ETF Growth0207.49 CR0.2
Axis Nifty Smallcap 50 Index Fund Growth0638.56 CR1.05
Nippon India Nifty Pharma ETF Growth01570.17 CR
Axis Silver ETF Growth02163.42 CR0.42
ICICI Prudential Silver ETF Growth015985.7 CR0.4
Fund Name1Y3Y
This FundICICI Prudential Nifty Auto ETF Growth15.693184.9862
This FundAxis Nifty Smallcap 50 Index Fund Growth3.761485.494
This FundNippon India Nifty Pharma ETF Growth13.150686.1246
This FundAxis Silver ETF Growth116.7584222.3264
This FundICICI Prudential Silver ETF Growth117.5488222.9939

Nippon India Nifty Pharma ETF Growth FAQs

Nippon India Nifty Pharma ETF Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of Nippon India Nifty Pharma ETF Growth is . This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

Nippon India Nifty Pharma ETF Growth’s fund performance is as follows:
  • 1 Month : -1.86%
  • 6 Months : 7.88%
  • 1 Year : 13.15%
  • 3 Years : 23.01%
Returns of Nippon India Nifty Pharma ETF Growth are updated daily based on NAV of ₹ 25.1097 as on Jun 19,2026. Since inception, the return has been 86.12%.

You can invest in Nippon India Nifty Pharma ETF Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of Nippon India Nifty Pharma ETF Growth is ₹1,570 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in Nippon India Nifty Pharma ETF Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.